In last trading session, CERo Therapeutics Holdings Inc (NASDAQ:CERO) saw 5.96 million shares changing hands with its beta currently measuring 0.47. Company’s recent per share price level of $0.96 trading at -$0.4 or -29.40% at ring of the bell on the day assigns it a market valuation of $2.91M. That closing price of CERO’s stock is at a discount of -39066.67% from its 52-week high price of $376.00 and is indicating a discount of -31.25% from its 52-week low price of $1.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.71 million shares which gives us an average trading volume of 666.55K if we extend that period to 3-months.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

Upright in the red during last session for losing -29.40%, in the last five days CERO remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $0.96 price level, adding 37.66% to its value on the day. CERo Therapeutics Holdings Inc’s shares saw a change of -84.00% in year-to-date performance and have moved -34.23% in past 5-day. CERo Therapeutics Holdings Inc (NASDAQ:CERO) showed a performance of -48.10% in past 30-days. Number of shares sold short was 0.29 million shares which calculate 0.55 days to cover the short interests.

CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s Major holders

Insiders are in possession of 18.77% of company’s total shares while institution are holding 4.47 percent of that, with stock having share float percentage of 5.50%. Investors also watch the number of corporate investors in a company very closely, which is 4.47% institutions for CERo Therapeutics Holdings Inc that are currently holding shares of the company.